NuMe Health logo

Management Team

Dean P. Stull, Ph.D. - President and CEO
Dr. Stull, an entrepreneur and expert in the development of pharmaceuticals derived from botanicals, was the founder and principal of Innovation Science, which provides consulting services for biotechnology, medical food and specialized functional food companies. He currently serves as chairman of the board of Pyxant Laboratories, which provides bioanalytical services for preclinical and clinical development programs. Previously, Dr. Stull was chief scientific officer of medical foods company Efficas. Prior to Efficas, he was president of InB: Hauser Pharmaceutical Services and president of InB: Paxis Pharmaceuticals, which he founded. Earlier, Dr. Stull was a founder and served as CEO and president of biotechnology company Hauser, a Nasdaq-listed public company. He received a B.S. degree from Colorado State University and M.S. and Ph.D. degrees from the University of Colorado at Boulder.

Mark Heiman, Ph.D. - Vice President of Research & Chief Scientific Officer
Dr. Heiman is a leading academic and industrial researcher in endocrinology and obesity. Prior to joining NuMe Health, he worked at Eli Lilly for more than 20 years, where he held positions of increasing responsibility in endocrine-related drug discovery and development. Most recently, Dr. Heiman served as chief scientific officer of the obesity drug discovery team and as a research fellow in the division of endocrinology. Dr. Heiman has co-authored 90 scientific publications and helped develop 30 drug-related patents. He received a B.A. from the University of New Orleans, a Ph.D. from Louisiana State University School of Medicine and completed a post doctoral research fellowship at Indiana University School of Medicine.

Justin Peno, M.B.A. - Director of Business Development
Mr. Peno has more than a decade's management and business development experience in the healthcare industry. Previously, he served as a Fellow of the New Orleans BioInnovation Center, focusing on the commercialization of biotechnologies pioneered by local universities and helping to steer two technologies through the commercialization process into promising start-up ventures. Mr. Peno received a B.A. from Louisiana State University and an M.B.A. from the Freeman School of Business at Tulane University.


Website and Contents Copyright © NuMe Health